key: cord-1005308-hz0hmy7s
authors: Du, Pengcheng; Song, Chuan; Li, Rui; Song, Yangzi; Li, Jiarui; Ding, Nan; Zhang, Ju; Song, Rui; Han, Junyan; Gao, Guiju; Yue, Jinglin; Duan, Ang; Huang, Yanyi; An, Jing; Wang, Jianbin; Zhang, Fujie; Chen, Chen; Zeng, Hui
title: Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract
date: 2020-10-22
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1617
sha: fe615f084ab69722070beb6951fe782699128c95
doc_id: 1005308
cord_uid: hz0hmy7s

Intra-host analysis of SARS-CoV-2 genomic sequences identified two viral haplotypes that comprised of three genetically linked mutations from the respiratory and intestinal tracts of a patient with COVID-19. Spatiotemporal data suggest that this patient initially had dual-infection of two SARS-CoV-2 variants, which subsequently re-distributed into the two systems.

The coronavirus disease 2019 (COVID-19) pandemic has engendered a growing global health crisis with unpredictable long-term consequences for human health. [1, 2] The causative agent of COVID-19, SARS-CoV-2, is transmitted by direct contact and exhaled respiratory droplets, with increasing evidences of potential fecal-oral transmission. [3] SARS-CoV-2 RNA has been detected in respiratory tract specimens and feces for weeks after acute infection. Live virus has been cultured from multiple sample types, including feces. [4, 5] In addition to airway epithelial cells, human intestinal epithelium has been shown to be a productive site of SARS-CoV-2 replication, suggesting that the intestine may be an alternative target organ for SARS-CoV-2. [6] Genetic variation driven by SARS-CoV-2 adaptions occurring between and within human hosts may have important effects on the transmissibility and pathogenicity of the virus. To date, studies have documented over 19,000 SARS-CoV-2 mutations in the public databases. [7] The genomic heterogeneity of the virus also existed within individual patients, [8] although it is still unclear whether these genetic variations represent specific adaptations to different organs. Here, by using deep sequencing, we identified two distinct SARS-CoV-2 variants in a COVID-19 patient distinguished by three genetically linked mutations and observed changes in the distribution of these variants in specimens collected from the respiratory and intestinal tracts of the patient during the course of their infection.

A 30-year-old man was tested positive for SARS-CoV-2 RNA by quantitative RT-PCR (qRT-PCR), and admitted to Beijing Ditan hospital on February 29, 2020. He had contact with a confirmed COVID-19 patient on February 18. Prior to the admission, he exhibited mild symptoms (sore throat, dry cough and runny nose), but no fever or diarrhea ( Figure S1 ).

During hospitalization, chest CT scans taken on hospital days 1 and 14 were normal. He was treated with alpha-interferon, but no other antiviral medication. The patient's pharyngeal swabs, sputum and feces were collected at 3-day intervals and tested by qRT-PCR to monitor A c c e p t e d M a n u s c r i p t 5 virus load; the last positive test was carried on hospital day 33 ( Figure S1 ). Additionally, serum specimens collected on hospital days 10, 18 and 26 were tested for SARS-CoV-2specific antibodies. IgM antibodies were negative at all three time points and IgG antibodies were positive on days 18 and 26 ( Figure S1 ). The patient was discharged on day 37 in accordance with the Chinese Diagnosis and Treatment Protocols (no clinical symptoms and two consecutive negative qRT-PCR tests).

SARS-CoV-2 genome sequencing was conducted using two strategies to confirm sequence data: (i) whole metatranscriptome sequencing using a TNBSEQ-T7 platform and (ii) targeted SARS-CoV-2 sequencing on an Illumina NextSeq500 (Supplementary methods). After patient admission and consenting, the parallel sequencing using the two strategies was performed on three samples (pharyngeal swab, sputum and feces) collected on March 3, 2020 (hospital day 4, Table S1 and S2). Sequence comparison to the reference genome (Wuhan-Hu-1, accession number: NC_045512.2) revealed six high quality SNPs (C884T, G1397A, G8653T, G11083T, T28688C and G29742T) in all three samples ( Figure 1A ). The first four SNPs were located in ORF1a and led to non-synonymous mutations (R207C, V378I, M2796I and L3606F); the other two synonymous SNPs were located in the N gene (T28688C) and the 3'-UTR region (G29742T), respectively ( Figure 1A ). The six unique SNPs were not detected in other patients in our hospital during the same period.

We further analyzed the sequence data for the presence of iSNVs in the three samples. We detected four iSNVs (C8481T, C22000A, T26975G and G28812T - Figure 1B ) in the pharyngeal swab and sputum samples, three (C8481T, C22000A, and G28812T) of which have been identified as SNP sites previously. [7] These four iSNVs were located in the ORF1a, S, M and N genes, respectively, and led to nonsynonymous mutations ( Figure 1B ). In the pharyngeal swab sample, the mutation allele frequencies (MuAFs) at these four sites (C8481T, C22000A, T26975G and G28812T) were 0%, 6.25%, 8 (Table S3 ). In the fecal sample, we detected 1,088 T nucleotides at position 26,975, and 289 G nucleotides at position 28,812 of the genome.

We did not find any alternative allele at either of these two sites, which suggested that Variant II was extremely low in feces.

To investigate any spatiotemporal changes in the two genetic variants over the course of infection, we performed a follow-up sequencing analysis on pharyngeal swab, sputum and feces samples collected on hospital days 10 or 11. We confirmed the presence of the same six SNPs originally identified on hospital day 4. However, the distribution of iSNV MuAFs was significantly different ( Figure S5 , Table S3 ). Variant I became overwhelmingly dominant (>99%) in the pharyngeal swab and sputum, though we still observed a few reads supporting continued presence of Variant II in pharyngeal swab (0.07%) and sputum (0.04%, Figure   1D ). In feces, the variant distribution was profoundly reversed, with Variant II predominating and only 0.04% of Variant I, despite the fact that this was the only variant detectable in the fecal sample on hospital day 4. This might be caused by stochastic sampling of the extremely low proportion minor variants in feces at the two time points ( Figure S6 ). These results based on MuAFs at the three iSNV sites revealed dynamic changes in distribution of the variant types in respiratory and gastrointestinal systems.

Here, we present spatiotemporal dynamic of molecular data demonstrating that two SARS-CoV-2 variants might initially co-infect the respiratory tract of a single patient. The case presented here is a young adult with mild symptoms, and without being subjected to specific anti-viral therapy, except for atomized alpha-interferon. Our results were supported by sequencing data from both whole metatranscriptome sequencing and targeted SARS-CoV-2 A c c e p t e d M a n u s c r i p t 7 sequencing. The ultra-deep sequencing provides high quality unbiased data, and the targeted approach extended the coverage and sequencing depth of the viral genome (Table S2, Figure   S2 ). Spatiotemporal analysis of the iSNVs provided concrete evidences to support the notion that a dual SARS-CoV-2 infection occurred in this patient. For instance, three iSNVs were highly genetically linked in both pharyngeal swabs and sputum in the early stage of infection 

A Novel Coronavirus from Patients with Pneumonia in China

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Presence of Live SARS-CoV-2 Virus in Feces of Coronavirus Disease 2019 (COVID-19) Patients: A Rapid Review

SARS-CoV-2 productively infects human gut enterocytes

Global initiative on sharing all influenza data -from vision to reality

Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease

Clinical Characteristics of Coronavirus Disease 2019 in China

Evolution of viral quasispecies during SARS-CoV-2 infection

SARS-CoV-2 Quasispecies provides insight into its genetic dynamics during infection

SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies

A c c e p t e d M a n u s c r i p t 10 A c c e p t e d M a n u s c r i p t 11